Eli Lilly first studied the effectiveness of using a RET inhibitor as a treatment for early-stage non-small cell lung cancer. The company's drug, Retevmo, significantly increased the survival rate of participants in the final studies.
Amazon has begun installing the first pharmacy kiosks in its clinics, allowing patients to pick up their medications immediately after seeing a doctor. Professional pharmacist associations have spoken out against the innovation.
A new study has found that AbbVie's drug Atogepant can work as an emergency treatment for migraines. The tablets relieved headaches and symptoms characteristic of the disease in 24% of participants within two hours — almost twice as effective as a placebo.
The FDA has approved the use of the first GLP-1 agonist in tablet form to reduce the risk of heart attack, stroke, and death from heart disease in people with type 2 diabetes. The drug is Novo Nordisk's Rebelsas (semaglutide).
Semaglutide and tirzepatide have been added to the WHO's updated list of essential medicines. However, the organization has not recommended using these drugs separately for treating obesity. The list also includes drugs for cancer and cystic fibrosis.
WEBBERRY Company business activity:
The company provides on-demand periodical web-digest and expert-opinion reports for selected markets and industries about key players, important events, emerging trends and latest news.
